CANTON, Conn., May 14, 2012 /PRNewswire/ --Kelyniam (Pinksheets:KLYG.PK) On May 11th at 2pm, local time, the 2012 Annual Meeting of Stockholders of Kelyniam Global Inc. was held at the company's headquarters located at 97 River Road, Canton, CT 06019. The matters listed below were submitted to a vote of the shareholders through solicitation of proxies. The final results of the shareholder votes are as follows:
Proposal 1 - Amendment to Articles of Incorporation - Increase of Authorized Shares
The shareholders approved the proposal to increase the authorized shares of common stock from 20,000,000 to 60,000,000 shares.
For | 9,086,522 |
Against | 1,435,015 |
Proposal 2 - Amendment to Articles of Incorporation - Authorization of Creation of a Preferred Class
The shareholders approved the proposal to authorize a creation of a preferred class of shares.
For | 7,654,377 |
Against | 2,867,160 |
Proposal 3 - Election of Directors
The shareholders elected each director nominated to serve for a term of one year.
a.) Tennyson S. Anthony Esq. | |
For | 9,232,528 |
Against | 1,275,509 |
b.) Nicholas Breault | |
For | 10,475,037 |
Against | 33,000 |
c.) Dr. Christopher Mirucki | |
For | 10,062,228 |
Against | 445,809 |
d.) Christopher Breault | |
For | 9,138,089 |
Against | 1,369,948 |
About Kelyniam Global, Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.
Please visit our website atwww.kelyniam.com for more information.
Forward-Looking Statements
Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this release, words such as "anticipate," "believes," "estimate," "expect," "should," "intend," "projects," "objective" and "appears" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; the impact of reimbursement rates and coverage; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments.
For Question regarding this Press Release, please contact:
Kelyniam Global Inc.
Michael Hamblett, 800-280-8192 x3
Director of Investor Relations
SOURCE Kelyniam
